Evaluating Proliferation Markers in Anaplastic Astrocytomas
Author Information
Author(s): Habberstad Andreas H, Gulati Sasha, Torp Sverre H
Primary Institution: Norwegian University of Science and Technology
Hypothesis
The study aims to evaluate and compare novel immunohistochemical proliferative markers in human anaplastic astrocytomas.
Conclusion
The study suggests that these markers may significantly assist in evaluating proliferative activity in anaplastic astrocytomas and have prognostic value.
Supporting Evidence
- The markers correlated well with each other, indicating their potential utility in assessing tumor proliferation.
- Positive association to overall survival was observed with the proliferation markers.
- Ki-67/MIB-1 and pHH3 indicated poorer survival in univariate analyses.
Takeaway
Doctors are trying to find better ways to tell how fast brain tumors are growing, and this study looks at new markers that might help with that.
Methodology
The study analyzed 27 cases of anaplastic astrocytomas using antibodies against various proliferation markers and correlated them with clinical data.
Limitations
The study's findings may be limited by the small sample size and the challenges in identifying mitotic figures in small biopsies.
Participant Demographics
The study included 27 patients (10 women and 17 men) with a median age of 49 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI, 8-48 months
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website